Topic: Oncology drugs

Merck

5. Merck & Co.

Propelled by immuno-oncology superstar Keytruda, Merck posted strong growth in 2019 and reached $46.84 billion in global sales. Merck was a standout performer among its Big Pharma peers, and now the company is shaking up its structure with a sizable spinoff.